Cargando…
The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain
Fosfosal is the O‐phosphorylated derivative of salicylic acid, with documented clinical use as a prodrug for the treatment of inflammatory diseases. We recently discovered that fosfosal itself inhibits the protein‐protein interaction domain, the SH2 domain, of the tumor‐related transcription factor...
Autores principales: | Gräb, Julian, Berg, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496286/ https://www.ncbi.nlm.nih.gov/pubmed/32227557 http://dx.doi.org/10.1002/cbic.202000111 |
Ejemplares similares
-
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a**
por: Elumalai, Nagarajan, et al.
Publicado: (2015) -
Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
por: Eckhardt, Katrin S., et al.
Publicado: (2022) -
Stafia‐1: a STAT5a‐Selective Inhibitor Developed via Docking‐Based Screening of in Silico O‐Phosphorylated Fragments
por: Natarajan, Kalaiselvi, et al.
Publicado: (2019) -
A High-Throughput Fluorescence Polarization-Based Assay for the SH2 Domain of STAT4
por: Berg, Angela, et al.
Publicado: (2022) -
Involvement of the Arg(566) residue of Aeromonas sobria serine protease in substrate specificity
por: Kobayashi, Hidetomo, et al.
Publicado: (2017)